These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10917559)
61. Phenolphthalein: a sheep in wolf's clothing? Holden HE Environ Mol Mutagen; 1998; 31(2):103-4. PubMed ID: 9544187 [No Abstract] [Full Text] [Related]
62. Studies on the laxative activity of triphenylmethane derivatives; physicochemical aspects of the potency difference between yellow phenolphthalein and U.S.P. phenolphthalein. LOEWE S; LOEWE IA Arch Int Pharmacodyn Ther; 1949 Aug; 80(2-3):236-45. PubMed ID: 18137859 [No Abstract] [Full Text] [Related]
63. A soluble phenolphthalein laxative. ROSENTHAL M; CAIRNCROSS SE; GRAY MG Am J Dig Dis; 1947 Apr; 14(4):143-50. PubMed ID: 20294358 [No Abstract] [Full Text] [Related]
64. Studies on the laxative activity of triphenylmethane derivative; the relation between water-repellency and activation of phenolphthalein preparations and the concept of floto activation. LOEWE S; LOEWE IA Arch Int Pharmacodyn Ther; 1950 Feb; 81(2):195-206. PubMed ID: 15410271 [No Abstract] [Full Text] [Related]
65. [Phenolphthalein as laxative and kidney damage]. Egert H; Fritzer W; Ullrich D Wien Z Inn Med; 1969; 50(3):117-21. PubMed ID: 5362179 [No Abstract] [Full Text] [Related]
66. [Abuse of laxatives as the cause of obscure prolonged diarrhea]. Blomquist L; Svensson H; Lindhagen J; Oberg K Lakartidningen; 1989 Oct; 86(41):3467-70. PubMed ID: 2796544 [TBL] [Abstract][Full Text] [Related]
67. Phenolphthalein-induced fixed drug eruption: a cutaneous complication of laxative use in a child. Zanolli MD; McAlvany J; Krowchuk DP Pediatrics; 1993 Jun; 91(6):1199-201. PubMed ID: 8502530 [No Abstract] [Full Text] [Related]
68. [Phenolphthalein as a laxative]. KREBS KG Ther Ggw; 1952 Aug; 91(8):298-300. PubMed ID: 13005455 [No Abstract] [Full Text] [Related]
69. Patterns of laxative use in self-medication. Théophile H; Miremont-Salamé G; Abouelfath A; Bégaud B; Haramburu F Ann Pharmacother; 2009 Dec; 43(12):2122-3. PubMed ID: 19934387 [No Abstract] [Full Text] [Related]
72. Laxative studies. I. Human threshold doses of white and yellow phenolphthalein. MUNCH JC; CALESNICK B Clin Pharmacol Ther; 1960; 1():311-5. PubMed ID: 14425224 [No Abstract] [Full Text] [Related]
74. Noncontraceptive estrogen use and the occurrence of ovarian cancer. La Vecchia C; Liberati A; Franceschi S J Natl Cancer Inst; 1982 Dec; 69(6):1207. PubMed ID: 6958899 [No Abstract] [Full Text] [Related]
75. Purging and calorie absorption in bulimic patients and normal women. Bo-Linn GW; Santa Ana CA; Morawski SG; Fordtran JS Ann Intern Med; 1983 Jul; 99(1):14-7. PubMed ID: 6190422 [TBL] [Abstract][Full Text] [Related]
77. Laxatives: chemical structure and potency of phthaleins and hydroxyanthraquinones. HUBACHER MH; DOERNBERG S; HORNER A J Am Pharm Assoc Am Pharm Assoc; 1953 Jan; 42(1):23-30. PubMed ID: 13034620 [No Abstract] [Full Text] [Related]
78. [Diverticulitis and laxatives]. Riecken EO Dtsch Med Wochenschr; 1982 Oct; 107(40):1529. PubMed ID: 7117171 [No Abstract] [Full Text] [Related]
79. Estimating risks for matching factors in case-control studies. Siskind V; Kelly JP; Kaufman DW J Clin Epidemiol; 2000 Mar; 53(3):251-6. PubMed ID: 10760634 [TBL] [Abstract][Full Text] [Related]
80. Movement away from phenolphthalein in laxatives. Murphy J JAMA; 2009 May; 301(17):1770; author reply 1770. PubMed ID: 19417193 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]